Canada Markets open in 2 mins

Banco Santander, S.A. (SAN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.8400+0.1200 (+4.41%)
At close: 04:00PM EDT
2.8100 -0.03 (-1.06%)
Pre-Market: 09:22AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.7200
Open2.8000
Bid2.8200 x 40700
Ask0.0000 x 21500
Day's Range2.7901 - 2.8600
52 Week Range2.6800 - 4.3800
Volume5,897,779
Avg. Volume7,761,848
Market Cap48.411B
Beta (5Y Monthly)1.80
PE Ratio (TTM)8.53
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.09 (2.60%)
Ex-Dividend DateOct 29, 2021
1y Target EstN/A
  • Business Wire

    Santander Bank Raises Its Prime Rate to 4.00%

    BOSTON, May 04, 2022--Santander Bank announced today it has raised its prime rate from 3.50% to 4.00%, effective May 4, 2022.

  • GlobeNewswire

    Press Release: Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation

    Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation Dupixent is the only biologic indicated in the European Union for severe asthma with type 2 inflammation, characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide Approval based on Phase 3 data showing Dupixent significantly reduced severe asthma attacks and also improved lung function and health-related quality of life for childrenData

  • GlobeNewswire

    Press Release: Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board

    Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board Paris, April 4, 2022. Sanofi launches today its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors. Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer